Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities

Friedmann, Zoe; Kinkel, Hans-Tilmann; Kuehner, Claudia; Zsolnai, Andreas; Mick, Inge; Binder, Annette

dc.contributor.author	Binder, Annette
dc.date.accessioned	2024-05-27T07:06:41Z
dc.date.available	2024-05-27T07:06:41Z
dc.date.issued	2023
dc.identifier.issn	1477-7517
dc.identifier.uri	http://hdl.handle.net/10900/153673
dc.language.iso	en	de_DE
dc.publisher	London : Bmc	de_DE
dc.relation.uri	http://dx.doi.org/10.1186/s12954-023-00896-6	de_DE
dc.subject.ddc	150	de_DE
dc.subject.ddc	610	de_DE
dc.title	Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240124000000_00521
utue.personen.roh	Friedmann, Zoe
utue.personen.roh	Kinkel, Hans-Tilmann
utue.personen.roh	Kuehner, Claudia
utue.personen.roh	Zsolnai, Andreas
utue.personen.roh	Mick, Inge
utue.personen.roh	Binder, Annette
dcterms.isPartOf.ZSTitelID	Harm Reduction Journal	de_DE
dcterms.isPartOf.ZS-Issue	Article 162	de_DE
dcterms.isPartOf.ZS-Volume	20 (1)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE